25503-87-1 Usage
Uses
Used in Pharmaceutical Industry:
Phenyl-3-pyrrolidinyl-Methanone HCl is used as an analgesic agent for its potent pain-relieving properties. It is particularly effective in managing moderate to severe pain and has been considered a replacement for other opioids in medical settings.
Used in Medical Research:
In the field of medical research, Phenyl-3-pyrrolidinyl-Methanone HCl serves as a valuable compound for studying the mechanisms of action and potential therapeutic applications of opioids. Its role as a μ-opioid receptor agonist provides insights into the development of new analgesics and pain management strategies.
Used in Regulatory and Legal Frameworks:
Phenyl-3-pyrrolidinyl-Methanone HCl is utilized in the development and enforcement of regulatory and legal frameworks surrounding controlled substances. Its classification as a controlled substance and potential for abuse and dependence necessitate strict regulations to prevent misuse and ensure the safe and effective use of the compound in medical practice.
Check Digit Verification of cas no
The CAS Registry Mumber 25503-87-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,5,0 and 3 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 25503-87:
(7*2)+(6*5)+(5*5)+(4*0)+(3*3)+(2*8)+(1*7)=101
101 % 10 = 1
So 25503-87-1 is a valid CAS Registry Number.
InChI:InChI=1S/C11H13NO.ClH/c13-11(10-6-7-12-8-10)9-4-2-1-3-5-9;/h1-5,10,12H,6-8H2;1H
25503-87-1Relevant academic research and scientific papers
AMIDE COMPOUNDS
-
Page/Page column 147; 149, (2008/06/13)
The present invention provides compounds represented by the formula (Ie) and the formula (If) wherein each symbol is as defined in the specification. According to the present invention, these compounds have a DGAT inhibitory activity and are useful for the prophylaxis, treatment or improvement of diseases or pathologies caused by high expression or high activation of DGAT